If a genetic test told you that you carry an MTHFR variant, here is the short answer: for the two common variants, that result almost never changes what you should do. Both are extremely common. An estimated 25 percent of Hispanics and 10 to 15 percent of North American whites have the most talked about one in both copies of the gene, according to MedlinePlus Genetics. Something that common is not a diagnosis. Major medical societies recommend against ordering the test in routine practice, and we agree with them.
That is not a popular position in functional medicine. It is the honest one.
What the MTHFR gene actually does
MTHFR is the instruction manual for an enzyme that converts one form of folate into another, called 5-methyltetrahydrofolate. Your body uses that converted folate to turn homocysteine, an amino acid, back into methionine. Methionine feeds methylation, a set of reactions involved in building DNA, making neurotransmitters and regulating gene expression.
Methylation is real biochemistry and it matters. The leap made online is the next one, that a common variant meaningfully breaks that pathway and you need a supplement protocol to fix it.
The two common variants, and what they really do
The two variants you will see on a report are usually written as 677C>T and 1298A>C. Both mildly reduce how well the enzyme works. Carrying two copies of 677C>T can produce a mild rise in blood homocysteine, and that effect is strongest in people who are also low in folate.
A recent review of MTHFR testing puts it plainly. The homozygous forms of these polymorphisms reduce enzyme production only mildly, and the current consensus is that without elevated homocysteine, MTHFR variants alone are not a risk factor for any disease.
That last clause is the point. The variant is not the thing to measure. Homocysteine is.
Why the guidelines say not to test
In 2013 the American College of Medical Genetics and Genomics published a practice guideline stating that MTHFR polymorphism testing has minimal clinical utility and should not be ordered in routine evaluation for thrombophilia, recurrent pregnancy loss, or at-risk family members.
The original hypothesis did not survive contact with the data. The idea was that reduced enzyme activity raises homocysteine, which raises the risk of clots, heart disease and miscarriage. Later analyses did not find the expected link between MTHFR genotype and venous thromboembolism, or between the variants and poor pregnancy outcomes. ACOG says the same in its guidance on inherited thrombophilias in pregnancy, and the College of American Pathologists, the American Academy of Family Physicians and the American Heart Association discourage the test as well.
The homocysteine trials are the uncomfortable part
Even where homocysteine is genuinely elevated, lowering it has disappointed as a treatment. A 2017 Cochrane review pooled 15 randomized trials covering more than 71,000 people. B vitamin supplements lowered homocysteine reliably but did not prevent heart attacks and did not reduce overall mortality. There was a modest signal for stroke reduction, which the authors said should be viewed with caution. B vitamins move the number, but the number turned out to be a weaker lever on outcomes than anyone hoped.
Methylfolate versus folic acid
The standard pitch is that people with MTHFR variants cannot process folic acid and must take methylfolate instead. The reality is softer. Methylfolate is a legitimate supplement, but there is no good trial evidence that choosing it by genotype improves health outcomes, and no guideline recommends picking your folate form from an MTHFR result.
The evidence that does exist is for plain folic acid. The US Preventive Services Task Force gives a Grade A recommendation that everyone planning or capable of pregnancy take 400 to 800 micrograms of folic acid daily, starting at least a month before conception. That recommendation is not conditioned on genotype. If you are pregnant or trying to conceive, take the folic acid, and do not skip it because a report frightened you about it.
One genuine caution: very high doses of folic acid can mask a vitamin B12 deficiency while nerve damage continues underneath.
The rare version that is a real diagnosis
There is a severe form of MTHFR deficiency, a real inborn error of metabolism caused by rare variants rather than the common two. NCBI’s Medical Genetics Summaries describes extremely high homocysteine in blood and urine alongside low methionine, with developmental delay, eye disorders, thrombosis and osteoporosis. It announces itself in infancy or childhood, not as a surprise on an adult wellness panel, and it is confirmed with full gene sequencing rather than a two-variant screen.
If you are a healthy adult who ordered a consumer gene report, this is almost certainly not you.
What is worth checking instead
If methylation concerns brought you in, the useful workup is not genetic. It is measuring homocysteine, vitamin B12 and folate, then looking for why they are off. Low intake, heavy alcohol use, long term metformin or acid suppressing medication, kidney function and thyroid status all shift these numbers, and all are treatable. This is the same principle we apply to vitamin D testing and the reason we do not use IgG food sensitivity tests. A test earns its place by changing a decision.
Red flags that need a clinician, not a supplement
- An unexplained blood clot in a leg or lung, or a stroke or heart attack at a young age
- Recurrent pregnancy loss
- A markedly elevated homocysteine level on repeat testing
- Numbness, tingling, balance problems or memory change, which can signal B12 deficiency
- A child with developmental delay, seizures or unexplained clotting
Those deserve a proper evaluation. None are answered by an MTHFR panel alone.
If you want your methylation questions answered with lab work rather than a genotype and a supplement stack, that is what our wellness and vitamin therapy visits are for, in Deerfield Beach or by telehealth across Florida.
Medically reviewed by Krishna Borges, MSN, APRN, FNP-C. This article is for general education and is not a substitute for individual medical advice.